1. Home
  2. BNBX vs NDRA Comparison

BNBX vs NDRA Comparison

Compare BNBX & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BNBX

Applied DNA Sciences Inc.

N/A

Current Price

$0.78

Market Cap

4.3M

ML Signal

N/A

Logo ENDRA Life Sciences Inc.

NDRA

ENDRA Life Sciences Inc.

N/A

Current Price

$3.01

Market Cap

4.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BNBX
NDRA
Founded
1983
2007
Country
United States
United States
Employees
26
N/A
Industry
Other Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.4M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
BNBX
NDRA
Price
$0.78
$3.01
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
63.7K
166.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
97.94
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$253.12
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.61
$2.92
52 Week High
$6.17
$11.91

Technical Indicators

Market Signals
Indicator
BNBX
NDRA
Relative Strength Index (RSI) 37.65 30.93
Support Level N/A N/A
Resistance Level $0.85 $3.78
Average True Range (ATR) 0.08 0.47
MACD 0.04 -0.04
Stochastic Oscillator 55.05 0.70

Price Performance

Historical Comparison
BNBX
NDRA

About BNBX Applied DNA Sciences Inc.

BNB Plus Corp focuses on digital asset treasury management of BNB. The group is unlocking institutional-grade access to the Binance ecosystem, delivering non-directional yield strategies and long BNB exposure, powering the future of blockchain through a transparent, actively managed BNB treasury. The Company's differentiated blends sophisticated DeFi yield generation with Binance-native opportunities, unlocking access to high-performance digital assets for investors traditionally excluded from the space.

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Share on Social Networks: